IP Library › Granted Patent US 7,604,810
Granted Patent B2
US 7,604,810 · App. 11/800,090 · Granted Oct 20, 2009

Conserved Neisserial antigens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,604,810
App. No.
11/800,090
Granted
Oct 20, 2009
Kind
B2
Abstract

To ensure maximum cross-strain recognition and reactivity, regions of proteins that are conserved between different Neisserial species, serogroups and strains can be used. The invention provides proteins which comprise stretches of amino acid sequence that are shared across the majority of Neisseria , particularly N. meningitidis and N. gonorrhoeae.

Claims (2)

1. An isolated protein fragment comprising the contiguous amino acid sequence QDMAAVS (SEQ ID NO: 225), provided that said protein fragment is not full length SEQ ID NOS:119-124.

2. The isolated protein fragment of claim 1 further comprising an adjuvant.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2016
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 040077/0493 →
CHANGE OF NAME Recorded Oct 23, 2009
From: CHIRON SRL
To: NOVARTIS VACCINES AND DIAGNOSTICS SRL
Reel/Frame 023417/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2009
From: RAPPUOLI, RINO
To: CHIRON SPA
Reel/Frame 023412/0113 →
CHANGE OF NAME Recorded Oct 22, 2009
From: CHIRON SPA
To: CHIRON SRL
Reel/Frame 023412/0138 →